The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 14, 2021

Filed:

Mar. 05, 2021
Applicant:

Tarsus Pharmaceuticals, Inc., Irvine, CA (US);

Inventors:

Bobak Robert Azamian, Newport Coast, CA (US);

Douglas Michael Ackermann, Reno, NV (US);

Shawn D. Hickok, Aliso Viejo, CA (US);

Joseph G. Vehige, Irvine, CA (US);

Assignee:

Tarsus Pharmaceuticals, Inc., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/42 (2006.01); A61K 31/422 (2006.01); A61K 47/26 (2006.01); A61P 27/02 (2006.01); A61P 33/14 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/422 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 47/26 (2013.01); A61P 27/02 (2018.01); A61P 33/14 (2018.01);
Abstract

Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.


Find Patent Forward Citations

Loading…